These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 16003116)

  • 1. Restless legs syndrome.
    Högl B; Poewe W
    Curr Opin Neurol; 2005 Aug; 18(4):405-10. PubMed ID: 16003116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treating restless legs syndrome: current pathophysiological concepts and clinical trials.
    Walther BW
    Expert Opin Investig Drugs; 2002 Apr; 11(4):501-14. PubMed ID: 11922859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Restless legs syndrome and periodic limb movements in sleep: pathophysiology and treatment].
    Wichniak A; Wierzbicka A; Jernajczyk W
    Neurol Neurochir Pol; 2003; 37(3):633-43. PubMed ID: 14593758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ropinirole treatment for restless legs syndrome.
    Molnar MZ; Fornadi K; Shapiro CM
    Drugs Today (Barc); 2006 Sep; 42(9):587-98. PubMed ID: 17028668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What treatment works best for restless legs syndrome? Meta-analyses of dopaminergic and non-dopaminergic medications.
    Hornyak M; Scholz H; Kohnen R; Bengel J; Kassubek J; Trenkwalder C
    Sleep Med Rev; 2014 Apr; 18(2):153-64. PubMed ID: 23746768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopamine agonists for the treatment of restless legs syndrome.
    Fulda S; Wetter TC
    Expert Opin Pharmacother; 2005 Dec; 6(15):2655-66. PubMed ID: 16316304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Restless legs syndrome--new insights into clinical characteristics, pathophysiology, and treatment options.
    Stiasny-Kolster K; Trenkwalder C; Fogel W; Greulich W; Hahne M; Lachenmayer L; Oechsner M; Oertel WH
    J Neurol; 2004 Sep; 251 Suppl 6():VI/39-43. PubMed ID: 15675724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Restless legs syndrome: pathophysiology and modern management.
    Nagandla K; De S
    Postgrad Med J; 2013 Jul; 89(1053):402-10. PubMed ID: 23524988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of restless legs syndrome: a familial case study.
    Snider S
    J Neurosci Nurs; 2013 Dec; 45(6):371-4. PubMed ID: 24217148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Restless legs syndrome in women: a review.
    Thomas K; Watson CB
    J Womens Health (Larchmt); 2008 Jun; 17(5):859-68. PubMed ID: 18537487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of α2δ Ligands for Restless Legs Syndrome/Willis Ekbom Disease.
    Faulkner MA
    CNS Drugs; 2018 Feb; 32(2):149-159. PubMed ID: 29480463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sleep Medicine: Restless Legs Syndrome.
    Bollu PC; Yelam A; Thakkar MM
    Mo Med; 2018; 115(4):380-387. PubMed ID: 30228773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An update on the dopaminergic treatment of restless legs syndrome and periodic limb movement disorder.
    Hening WA; Allen RP; Earley CJ; Picchietti DL; Silber MH;
    Sleep; 2004 May; 27(3):560-83. PubMed ID: 15164915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Restless legs syndrome.
    Venkateshiah SB; Ioachimescu OC
    Crit Care Clin; 2015 Jul; 31(3):459-72. PubMed ID: 26118915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ropinirole in patients with restless legs syndrome and baseline IRLS total scores ≥ 24: efficacy and tolerability in a 26-week, double-blind, parallel-group, placebo-controlled study followed by a 40-week open-label extension.
    Giorgi L; Asgharian A; Hunter B
    Clin Ther; 2013 Sep; 35(9):1321-36. PubMed ID: 23938061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of restless legs syndrome.
    Spolador T; Allis JC; Pondé MP
    Braz J Psychiatry; 2006 Dec; 28(4):308-15. PubMed ID: 17242812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. French consensus: Treatment of newly diagnosed restless legs syndrome.
    Limousin N; Flamand M; Schröder C; Charley Monaca C
    Rev Neurol (Paris); 2018; 174(7-8):515-521. PubMed ID: 30054010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pramipexole for restless legs syndrome promising].
    Füessl HS
    MMW Fortschr Med; 2014 Dec; 156(21-22):50. PubMed ID: 25608405
    [No Abstract]   [Full Text] [Related]  

  • 19. Efficacy of rotigotine for treatment of moderate-to-severe restless legs syndrome: a randomised, double-blind, placebo-controlled trial.
    Trenkwalder C; Benes H; Poewe W; Oertel WH; Garcia-Borreguero D; de Weerd AW; Ferini-Strambi L; Montagna P; Odin P; Stiasny-Kolster K; Högl B; Chaudhuri KR; Partinen M; Schollmayer E; Kohnen R;
    Lancet Neurol; 2008 Jul; 7(7):595-604. PubMed ID: 18515185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pregabalin versus pramipexole for restless legs syndrome.
    Allen RP
    N Engl J Med; 2014 May; 370(21):2050-1. PubMed ID: 24849090
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.